The coronavirus outbreak in China is starting to affect Cochlear's bottom line, as Chinese hospitals postpone non-essential surgery. More
By Graham Witcomb -
Graham Witcomb is a senior analyst at Intelligent Investor (under AFSL 282288), owned by InvestSMART Group. Graham has a degree in psychology from the University of Sydney and is a Chartered Financial Analyst charterholder. He previously worked for one of the world's most successful professional gamblers, and joined InvestSMART in 2013 where he focuses on healthcare, insurance and transport infrastructure. To unlock Intelligent Investor stock research and buy recommendations, take out a 15-day free membership.